Pneumococcal Conjugate Vaccine (PCV) under Universal Immunization Programme (UIP)

Prelims & Mains

Pneumococcal conjugate vaccine
Pneumococcal conjugate vaccine

No Child should die in the country from Vaccine Preventable Diseases.

Pneumococcal Conjugate Vaccine – PCV is a very important for children as it will provide protection cover to all the children below 5 years of age from pneumonia and meningitis.

Background of Pneumococcal disease

  • Pneumococcal disease is the leading cause of vaccine-preventable deaths in children under five years of age globally and in India.
  • India accounts for nearly 20% of global pneumonia deaths in this age group.
  • In 2010, pneumococcal pneumonia accounted for approximately 16% of all severe pneumonia cases
  • 30% of pneumonia related deaths in children under- five years of age in India.
  • “Pneumonia kills more children under five years of age in India than any other infectious disease.
  • The pentavalent vaccine which was scaled up in all states under the UIP by 2015 protects against Haemophilus influenza type b (Hib) pneumonia.

Introducing PCV, therefore, will substantially reduce disease burden in the country.

Pneumococcal conjugate vaccine
Pneumococcal conjugate vaccine

What is pneumococcal disease?

Pneumococcal disease is caused by bacteria, and can lead to infections in the lungs, blood, and brain. Each year, pneumococcal disease causes many health problems in children younger than 5 years of age, including meningitis blood infections, and ear infections.

Children younger than 2 years of age are at highest risk for serious disease. Vaccines are available to prevent the disease in children and adults.

What is the pneumococcal vaccine?

Pneumococcal conjugate vaccine (abbreviated PCV13) is a shot for infants and toddlers. It helps prevent pneumococcal disease, and it also helps stop the disease from spreading from person to person. It is now also being given to older adults.

Related Topics  MAA-Mother’s Absolute Affection

The vaccine’s protection lasts at least 3 years. Because most serious pneumococcal infections happen during the first 2 years of life, the vaccine protects children when they are at greatest risk.

Why should my child get this vaccine?

Pneumococcal conjugate vaccine can prevent pneumococcal disease. Pneumococcus bacteria are spread from person to person through close contact. Pneumococcal infections can be hard to treat because the disease has become resistant to some of the medicines that have been used to treat it. This makes preventing the disease even more important.

Who should get the pneumococcal conjugate vaccine and when?

The following groups of children should get this vaccine:

  • All children younger than 2 years of age. Healthy infants and toddlers should get 4 doses of pneumococcal conjugate PCV13 vaccine at the following periods of development:One dose at 2 months of age
  • One dose at 4 months of age
  • One dose at 6 months of age
  • One dose at 12 months to 15 months of age
Pneumococcal Conjugate Vaccine
Pneumococcal Conjugate Vaccine

Need for of Pneumococcal Conjugate Vaccine

  • The introduction of PCV in the UIP will reduce child deaths from pneumococcal pneumonia.
  • It will also reduce the number of children being hospitalized for pneumonia, and therefore reduce the economic burden on the families and the health cost burden on the country
  • No child should die in the country from Vaccine Preventable Diseases” is the Goal & Commitment of our government.
  • Govt of India stand committed to reducing child deaths and providing a healthier future to our children
  • Union Ministry for Health and Family Welfare  announced the introduction of pneumococcal conjugate vaccine (PCV) in the Universal Immunization Programme (UIP) of the country
  • Strengthening routine immunization is an essential investment in India’s children and will ensure a healthy future of the countryThe Government has taken notable steps in the direction of total immunisation.
Under Mission Indradhanush, so far, more than 2.6 crore beneficiaries have been immunized.
From 1% annual increase in coverage of Full Immunization, Mission Indradhanush has resulted in a 6.7 % annual expansion in the immunization cover.

“The immunization programme started with providing protection against 6 vaccine preventable diseases, it will now offer protection to our children from 12 diseases

Related Topics  Sustainable Action for Transforming Human capital (SATH)
Advertisements
Raja Raja Cholan
About Raja Raja Cholan 615 Articles
Trainer & Mentor for aspirants preparing for civil service examination

Be the first to comment

Leave a Reply